tiprankstipranks
Acrivon Therapeutics, Inc. (ACRV)
NASDAQ:ACRV
US Market

Acrivon Therapeutics, Inc. (ACRV) Stock Investors

109 Followers
Based on 736,049 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold ACRV
On average, investors allocate 0.00% of their portfolios to ACRV
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 736,049 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding ACRV

5.9%
Last 7
Days
10.9%
Last 30
Days
Percentages indicate the change in the number of portfolios holding ACRV, out of 736,049 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

ACRV Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Opened
0.00%
$7.25
Opened
0.31%
$7.15
Opened
0.31%
$7.15
Opened
0.30%
$7.15
Based on the activity of 13,878 investors who made their portfolios public
The table shows changes in ACRV in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

ACRV Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Riot Platforms
5.09%
-0.76%
-1.11%
2.88B
Financial
Coherus Biosciences
2.58%
-1.18%
-5.74%
230.60M
Healthcare
Merck & Company
4.13%
-0.10%
-0.62%
332.03B
Healthcare
Delta Air Lines
5.53%
-0.71%
-1.20%
33.04B
Industrials
Marathon Digital Holdings
5.63%
-0.78%
-3.02%
5.48B
Financial
DraftKings
6.06%
-0.51%
+0.55%
35.29B
Consumer Cyclical
Micron
5.68%
+1.09%
+2.44%
139.83B
Technology
Marvell
4.93%
+1.10%
+0.36%
64.93B
Technology
Zscaler
3.68%
+0.04%
+2.15%
25.76B
Technology
Nike
5.05%
-0.63%
-0.32%
137.96B
Consumer Cyclical
Based on the activity of 736,049 active portfolios
Open your Smart Portfolio

ACRV Investor Analysis

ACRV investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
0.0%
of ACRV holders
are under 35
Average Segment Performance
Average P/E Ratio23.14
Beta6.02
Dividend Yield6.25%
ACRV investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
25.0%
of ACRV holders
are between 35–55
Average Segment Performance
Average P/E Ratio22.00
Beta10.67
Dividend Yield6.42%
ACRV investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
75.0%
of ACRV holders
are over 55
Average Segment Performance
Average P/E Ratio21.70
Beta3.83
Dividend Yield7.17%
Overview of age group and performance of ACRV stock investors
See who invests in ACRV according to age group and performance.

FAQ

How many retail Investors hold ACRV?
<0.1% of TipRanks' retail investors hold ACRV in their portfolios.
    What is ACRV Investor Sentiment?
    ACRV’s Investor Sentiment is Very Positive.
      What percentage of retail investors changed their holding of ACRV in the last 7 days?
      ▲ 5.9% of TipRanks' retail investors changed their holding of ACRV in the last 7 days.
        What percentage of retail investors changed their holding of ACRV in the last 30 days?
        ▲ 10.9% of TipRanks' retail investors changed their holding of ACRV in the last 30 days.
          What is the average age of retail investors who hold ACRV?
          The average age of ACRV Holders is over 55.
            What other stocks have ACRV investors also bought?
            ACRV Investors also bought RIOT, CHRS, MRK, DAL, MARA, DKNG, MU, MRVL, ZS, NKE.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ACADACADIA Pharmaceuticals
              ALKSAlkermes
              BDXBecton Dickinson
              BCRXBioCryst
              CRMDCormedix
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis